www.ustoo.org    |   Donate  |    View in Browser

Made possible by a charitable contribution from Bayer
Navigation Tip: Click on blue text that’s italicized, underlined and in bold for link to more information.


We hope that you’re doing well as we provide some of the latest  Prostate Cancer News You Can Use . In addition to the following updates and information that may be of interest to you, the titles of prostate cancer news articles are listed below along with a link to the Us TOO web page that provides access to the full text for each article.

On November 9, we were very pleased to present the Prostate Cancer Pathways event and webcast in Chicago . Prostate cancer medical experts covered various topics identified as most important to men with prostate cancer, based on recent survey responses from Us TOO support group leaders. Presentations and panel discussions addressed:

  • Active Surveillance
  • Surgical Options & Side Effects
  • Prostate Cancer Radiotherapy
  • Prostate Cancer & the Penis
  • Prostate Cancer Patient Perspective
  • Genetics & Prostate Cancer
  • Advanced Prostate Cancer
  • Genomic/Molecular Testing & Bone Strength

We’d like to thank all Pathways event attendees and the online webcast audience, event hosts Northwestern Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, prostate cancer survivor and Us TOO support group leader Cliff Whall, medical expert presenters Nelson Bennett, Jr., MD; Maha Hussain, MD, FACP, FASCO; Shilajit D. Kundu, MD; Alicia Morgans, MD, MPH; Sean Sachdev, MD; David J. VanderWeele, MD, PhD; Genetic Counselor Carmen Williams; and event sponsors Astellas/Pfizer Oncology, Amgen, Genomic Health, Clovis Oncology, Dendreon, Advanced Accelerator Applications, Foundation Medicine, and Timm Medical Technologies Inc. Video from the Chicago event will be posted within the next few weeks.

Video is now available from the Us TOO Prostate Cancer Pathways event and webcast presented in Detroit on October 12 , featuring content from panel discussions on:

  • Biochemical Recurrent Prostate Cancer
  • Testosterone (the Fuel for Prostate Cancer)
  • Sexual Dysfunction  
  • Imaging & Scanning
  • Active Surveillance
  • Surgery 
  • Radiation
  • Hormone Therapy 
  • Shared Decision Making
  • Bone Health
  • PSA & Immunotherapy

Video content is labeled by specific topics for each segment for quick and easy access to brief segments or a recording of the entire webcast. Check out the video .

If you haven’t already done so, we encourage you to familiarize yourself with the value of the  Prostate Cancer Care Team Hub .  It’s a new tool from Us TOO designed to help men diagnosed with prostate cancer and their loved ones build the best healthcare team for their fight against the disease . The Hub is the result of collaboration between Us TOO and a wide range of healthcare professionals and organizations. The goal is to provide information about various prostate cancer specialists who may be needed along the journey of prostate cancer care and treatment. 

The call for nominations is now open for the second annual Cancer Community (C2) Awards ! The C2 awards spotlight those who are at the forefront of cancer care and celebrate the unsung heroes who make an enormous difference to patients and their families. Learn more at YOUR Cancer .


Please note that the content below lists only the title of the article rather than a direct link to the content. For access to the full article  CLICK HERE .

  • WPI researcher creating safer, more accurate way to detect prostate cancer

  • Researchers from Kyung Hee University Describe Findings in Prostate Cancer (Dietary Compounds for Targeting Prostate Cancer)

  • Reports Outline Prostate Cancer Findings from Department of Urology Surgery (Efficacy of Radical Prostatectomy Combined With Endocrine Drugs In Treatment of Elderly Patients With Prostate Cancer)

  • Mayo Clinic researchers find dairy products associated with higher risk of prostate cancer

  • Investigators from St. Orsola Marcello Malpighi Hospital Target Genitourinary Cancer (New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes)

  • Research from University of Oklahoma Reveals New Findings on Prostate Cancer (Urology perspective on the expanding world of germline testing for prostate cancer)

  • Findings in the Area of Prostate Cancer Reported from Keio University (Japanese Case of Enzalutamide-resistant Prostate Cancer Harboring a Spop Mutation With Scattered Allelic Imbalance: Response To Platinum-based Therapy)

  • Reports from Rutgers University Provide New Insights into Prostate Cancer (Biobehavioral effects of Tai Chi Qigong in men with prostate cancer: Study design of a three-arm randomized clinical trial)

  • Men over 40 with faulty BRCA2 gene should be tested annually for prostate cancer

  • Findings from Fred Hutchinson Cancer Research Center in the Area of Prostate Cancer Reported (Variations in prostate biopsy recommendation and acceptance confound evaluation of risk factors for prostate cancer: Examining race and BMI)

  • New Prostate Cancer Data Have Been Reported by Researchers at Kagoshima University (Oncological outcome of neoadjuvant low-dose estramustine plus LHRH agonist/antagonist followed by extended radical prostatectomy for Japanese patients with ...)

  • Reports Outline Prostatectomy Study Results from Sichuan University (The value of transperineal apical prostate biopsy in predicting urethral/apical margin status after radical prostatectomy)

  • New Prostate Cancer Care Team Web Portal Provides Resources for Managing the Disease


Journal Article recaps real‐world outcomes of sipuleucel‐T treatment in PROCEED, a prospective registry of men with metastatic castration‐resistant prostate cancer:

Article evaluates Clinically Relevant Drug–Drug Interactions and Population Pharmacokinetics of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer : Results of Pre-Specified and Post Hoc Analyses of the Phase III ARAMIS Trial:

A transcription factor that aids neuron function also appears to enable a cell conversion in the prostate gland that can make an already recurrent cancer even more deadly , scientists say:

We wish you a wonderful Thanksgiving and holiday season! Watch for the December issue of the Us TOO Hot SHEET newsletter, and let us know how we can help provide you with educational resources, support services and personal connections to others in the prostate cancer community.

All the best,

Chuck Strand, Chief Executive Officer
James Hutson, Development Director
Jackie Konieczka, Office Manager
Terri Likowski, Program Director - Support Group Services
Tim Mix, Communications Director